Analysts Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) PT at $115.36

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1 year price objective among […]

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand ,American ,Piper Sandler ,Roger Jeffs ,Robertw Baird ,Nasdaq ,Wellington Management Group ,Axsome Therapeutics Inc ,Sierra Summit Advisors ,Pricet Rowe Associates Inc ,Citigroup ,American International Group Inc ,Perceptive Advisors ,Axsome Therapeutics ,Get Free Report ,Director Roger Jeffs ,Management Group ,International Group ,Summit Advisors ,Pricet Rowe Associates ,Get Free ,Axsome Therapeutics Daily ,